Comments on: Gilead Sciences Refiles New Drug Application with the FDA for Single-Tablet Regimen of Truvada(R) and TMC278

Comments on: Gilead Sciences Refiles New Drug Application with the FDA for Single-Tablet Regimen of Truvada(R) and TMC278 https://www.worldpharmatoday.com/press-releases/gilead-sciences-refiles-new-drug-application-with-the-fda-for-single-tablet-regimen-of-truvadar-and-tmc278/ Magazine for the C-level Pharma Executives Wed, 09 Feb 2011 18:30:00 +0000 hourly 1 https://wordpress.org/?v=6.9.4